These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

165 related items for PubMed ID: 1664831

  • 1. Comparative pharmacokinetic disposition of fluoroquinolones in the lung.
    Wise R, Baldwin DR, Andrews JM, Honeybourne D.
    J Antimicrob Chemother; 1991 Dec; 28 Suppl C():65-71. PubMed ID: 1664831
    [Abstract] [Full Text] [Related]

  • 2. Penetration of sparfloxacin and ciprofloxacin into alveolar macrophages, epithelial lining fluid, and polymorphonuclear leucocytes.
    Schüler P, Zemper K, Borner K, Koeppe P, Schaberg T, Lode H.
    Eur Respir J; 1997 May; 10(5):1130-6. PubMed ID: 9163658
    [Abstract] [Full Text] [Related]

  • 3. Comparative penetration of selected fluoroquinolones into respiratory tract fluids and tissues.
    Wise R.
    Am J Med; 1991 Dec 30; 91(6A):67S-70S. PubMed ID: 1662897
    [Abstract] [Full Text] [Related]

  • 4. The distribution of temafloxacin in bronchial epithelial lining fluid, alveolar macrophages and bronchial mucosa.
    Baldwin DR, Wise R, Andrews JM, Ashby JP, Honeybourne D.
    Eur Respir J; 1992 Apr 30; 5(4):471-6. PubMed ID: 1314193
    [Abstract] [Full Text] [Related]

  • 5. Comparative bronchoalveolar concentrations of ciprofloxacin and lomefloxacin following oral administration.
    Baldwin DR, Wise R, Andrews JM, Gill M, Honeybourne D.
    Respir Med; 1993 Nov 30; 87(8):595-601. PubMed ID: 8290743
    [Abstract] [Full Text] [Related]

  • 6. The penetration of rufloxacin into sites of potential infection in the respiratory tract.
    Wise R, Andrews J, Imbimbo BP, Greaves I, Honeybourne D.
    J Antimicrob Chemother; 1993 Dec 30; 32(6):861-6. PubMed ID: 8144426
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Penetration of pefloxacin and ciprofloxacin into lung tissue.
    Scaglione F, Mezzetti M, Arcidiacono MM, Gattei G, Fraschini F.
    J Antimicrob Chemother; 1995 Apr 30; 35(4):557-9. PubMed ID: 7628993
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Pharmacokinetics of enrofloxacin and the rate of formation of its metabolite ciprofloxacin following intravenous and intramuscular single dose administration to male buffalo calves.
    Sharma PK, Ahmad AH, Sharma LD, Varma R.
    Vet J; 2003 Jul 30; 166(1):101-4. PubMed ID: 12788024
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Pulmonary disposition of lomefloxacin in patients with acute exacerbation of chronic obstructive pulmonary disease. A multiple-dose study.
    Cazzola M, Matera MG, Tufano MA, Catalanotti P, Polverino M, Cantoni V, Fici F, Sarlo F, Rossi F.
    J Chemother; 2001 Aug 30; 13(4):407-12. PubMed ID: 11589484
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.